Manager TitleAgeSince
Chief Executive Officer 58 24/04/2023
Director of Finance/CFO - 31/10/2024
Human Resources Officer 58 01/09/2015
Director TitleAgeSince
Chairman 53 24/04/2023
Director/Board Member 62 11/05/2018
Director/Board Member 73 11/05/2018
Date Insider Type Main position Quantity % Market Cap.
12/05/23
South Bay Ventures BV
BuyCompany 600,000 0.6419%
04/05/21 Free

Chief Technology Officer

15,000 0.0261%
04/05/21
Marcofin BV
Fiscal yearCompany 30,000 0.0521%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 31.4M
+0.08%+0.73%+29.25%+28.03% 12.88B
-0.71%-0.29%+16.57%+29.02% 6.88B
+5.91%+5.29%+52.36%+49.99% 6.46B
+0.65%+2.81% - - 5.66B
+0.14%+4.47%-26.77%+52.53% 4.56B
-1.67%-3.33%-25.92%-23.44% 3.91B
-2.47%+3.42%+44.50%-45.76% 1.97B
-1.98%-1.83%+54.20%-7.08% 1.71B
-0.58%-10.69%-33.93%+131.25% 1.55B
Average -0.07%+0.27%+13.78%+26.82% 5.06B
Weighted average by Cap. +0.49%+1.25%+18.37%+28.37%
Logo Biocartis Group NV
Biocartis Group NV specializes in the development of molecular diagnostic systems. Especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.
Employees
500
  1. Stock Market
  2. Stocks
  3. BCART Stock